Search

Search Constraints

You searched for: Author/Creator Weidinger, Stephan

Search Results

1. 345 Treatment with amlitelimab—a novel non-depleting, non-cytotoxic anti-OX40Ligand monoclonal antibody—reduces IL-22 serum levels in a phase 2a randomized, placebo-controlled trial in patients with moderate-to-severe atopic dermatitis. (25th January 2023)

2. 353 Amlitelimab reduces serum IL-13 in a phase 2a clinical trial in atopic dermatitis without impacting T-cell expansion in a T-cell recall assay. (25th January 2023)

3. A novel molecular disease classifier for psoriasis and eczema. Issue 10 (October 2016)

5. Allergy and asthma prevention 2014. Issue 6 (October 2014)